Model for inhibition of HCV NS5b polymerase by nucleoside analogs

被引：0
|
作者：
Perry, Jason K. [1 ]
机构：
[1] Gilead Sci Inc, Struct Chem, Foster City, CA 94404 USA
来源：
ABSTRACTS OF PAPERS OF THE AMERICAN CHEMICAL SOCIETY | 2011年 / 242卷
关键词：
D O I：
暂无
中图分类号：
O6 [化学];
学科分类号：
0703 ;
摘要：
202-COMP
引用
收藏
页数：1
相关论文
共 50 条
  • [21] 1,5-Benzodiazepine inhibitors of HCV NS5B polymerase
    McGowan, David
    Nyanguile, Origene
    Cummings, Maxwell D.
    Vendeville, Sandrine
    Vandyck, Koen
    Van den Broeck, Walter
    Boutton, Carlo W.
    De Bondt, Hendrik
    Quirynen, Ludo
    Amssoms, Katie
    Bonfanti, Jean-Francois
    Last, Stefaan
    Rombauts, Klara
    Tahri, Abdellah
    Hu, Lili
    Delouvroy, Frederic
    Vermeiren, Katrien
    Vandercruyssen, Genevieve
    Van der Helm, Liesbet
    Cleiren, Erna
    Mostmans, Wendy
    Lory, Pedro
    Pille, Geert
    Van Emelen, Kristof
    Fanning, Gregory
    Pauwels, Frederik
    Lin, Tse-I
    Simmen, Kenneth
    Raboisson, Pierre
    BIOORGANIC & MEDICINAL CHEMISTRY LETTERS, 2009, 19 (09) : 2492 - 2496
  • [22] Evaluation of Coumarin and Neoflavone Derivatives as HCV NS5B Polymerase Inhibitors
    Nichols, Daniel B.
    Leao, Raquel A. C.
    Basu, Amartya
    Chudayeu, Maksim
    de Moraes, Paula de F.
    Talele, Tanaji T.
    Costa, Paulo R. R.
    Kaushik-Basu, Neerja
    CHEMICAL BIOLOGY & DRUG DESIGN, 2013, 81 (05) : 607 - 614
  • [23] Discovery of a novel series of non-nucleoside thumb pocket 2 HCV NS5B polymerase inhibitors
    Stammers, Timothy A.
    Coulombe, Rene
    Rancourt, Jean
    Thavonekham, Bounkham
    Fazal, Gulrez
    Goulet, Sylvie
    Jakalian, Araz
    Wernic, Dominic
    Tsantrizos, Youla
    Poupart, Marc-Andre
    Boes, Michael
    McKercher, Ginette
    Thauvette, Louise
    Kukolj, George
    Beaulieu, Pierre L.
    BIOORGANIC & MEDICINAL CHEMISTRY LETTERS, 2013, 23 (09) : 2585 - 2589
  • [24] 3-Heterocyclyl quinolone inhibitors of the HCV NS5B polymerase
    Kumar, Dange V.
    Rai, Roopa
    Brameld, Ken A.
    Riggs, Jennifer
    Somoza, John R.
    Rajagopalan, Ravi
    Janc, James W.
    Xia, Yu M.
    Ton, Tony L.
    Hu, Huiyong
    Lehoux, Isabelle
    Ho, Joseph D.
    Young, Wendy B.
    Hart, Barry
    Green, Michael J.
    BIOORGANIC & MEDICINAL CHEMISTRY LETTERS, 2012, 22 (01) : 300 - 304
  • [25] DISCOVERY OF NOVEL HCV NS5B POLYMERASE INHIBITORS BY IN SILICO APPROACHES
    Karaman Mayack, Berin
    JOURNAL OF RESEARCH IN PHARMACY, 2023, 27 : 13 - 15
  • [26] Updateon different aspects of HCV variability: focus on NS5B polymerase
    Nadia Marascio
    Carlo Torti
    Maria Carla Liberto
    Alfredo Focà
    BMC Infectious Diseases, 14
  • [27] Update on different aspects of HCV variability: focus on NS5B polymerase
    Marascio, Nadia
    Torti, Carlo
    Liberto, Maria Carla
    Foca, Alfredo
    BMC INFECTIOUS DISEASES, 2014, 14
  • [28] The activity prediction of indole inhibitors against HCV NS5B polymerase
    Muhire, Jules
    Zhai, Hong Lin
    Lu, Shao Hua
    Li, Sha Sha
    Yin, Bo
    Mi, Jia Ying
    CHEMICAL BIOLOGY & DRUG DESIGN, 2020, 95 (02) : 240 - 247
  • [29] The First Kilogram Synthesis of Beclabuvir, an HCV NS5B Polymerase Inhibitor
    Bien, Jeffrey
    Davulcu, Akin
    DelMonte, Albert J.
    Fraunhoffer, Kenneth J.
    Gao, Zhinong
    Hang, Chao
    Hsiao, Yi
    Hu, Wenhao
    Katipally, Kishta
    Littke, Adam
    Pedro, Aghogho
    Qiu, Yuping
    Sandoval, Maria
    Schild, Richard
    Soltani, Michelle
    Tedesco, Anthony
    Vanyo, Dale
    Vemishetti, Purushotham
    Waltermire, Robert E.
    ORGANIC PROCESS RESEARCH & DEVELOPMENT, 2018, 22 (10) : 1393 - 1408
  • [30] Nucleoside Inhibitors of Hepatitis C Virus NS5B Polymerase: A Systematic Review
    Xie, Yuanchao
    Ogah, Comfort Alicha
    Jiang, Xiangrui
    Li, Jianfeng
    Shen, Jingshan
    CURRENT DRUG TARGETS, 2016, 17 (13) : 1560 - 1576
12345